Aspergillosis is an infection caused by the Aspergillus fungus or an allergic reaction to the fungus. Learn more about aspergillosis and the fungus that causes it.
WHAT IS IT?
Overview
Aspergillosis (pronounced a·sper·juh·low·suhs) is an infection or allergic reaction caused by a type of fungus called Aspergillus (pronounced as·per·gil·us).
There are several types of aspergillosis:
Allergic Forms |
Allergic Bronchopulmonary Aspergillosis (ABPA): An allergic reaction to the Aspergillus fungus causing lung inflammation. |
Allergic Fungal Rhinosinusitis: An allergic reaction to fungi (often including Aspergillus) in the nasal passages and sinuses. |
Severe Asthma with Fungal Sensitization (SAFS): A condition in which patients with severe asthma become sensitized to multiple fungi, with Aspergillus being the most common. |
Infectious Forms |
Aspergilloma: A condition in which a ball of Aspergillus grows in the lungs or sinuses. |
Chronic Pulmonary Aspergillosis (CPA): A long-term Aspergillus infection of the lungs. It persists for at least three months. |
Invasive Aspergillosis: This is the most serious form of the disease. In this condition, Aspergillus typically invades the lung (invasive pulmonary aspergillosis) or occasionally the sinuses and can spread to other organs. When Aspergillus infection involves many organs, it is called disseminated aspergillosis. |
Cutaneous (Skin) Aspergillosis: A condition in which Aspergillus is present in the skin. It occurs when Aspergillus enters the body through a break in the skin or spreads to the skin from somewhere else in the body. |
The Aspergillus fungus is everywhere. It is common both indoors and outdoors. We breathe in Aspergillus spores every day, but not every type of Aspergillus can make us sick. To learn more about the science of Aspergillus, see the Science Sidebar.
The Burden of Aspergillosis
How common is aspergillosis? We don’t know exactly how many people are affected by aspergillosis, because it is not tracked very closely. The allergic forms are more common than invasive aspergillosis. Worldwide, experts estimate that 4.8 million people have the allergic form ABPA, and over 1.8 million people have the infectious form CPA. In the United States, about 15,000 hospitalizations were tied to aspergillosis in 2014, with these infections costing about 1.2 billion dollars.
1.8 million
Annual worldwide incidence of chronic pulmonary aspergillosis (CPA)
What is the prognosis for aspergillosis? Most of the mild, allergic forms of aspergillosis do not lead to death, but they can have serious negative impacts on the day-to-day activities of those with the disease. In contrast, the infectious forms, particularly invasive aspergillosis, while less common and typically seen in immunocompromised patients, can be deadly. Right now, the 1-year survival rate for an organ-transplant patient with invasive aspergillosis is 59%. For stem-cell transplant recipients, it’s 25%. Read on to learn about strategies to improve these outcomes.